Accelerate Diagnostics Has Launched A Proposed Underwritten Public Offering Of 4.5M Each Consisting Of One Share Of Common Stock And One Warrant To Purchase One Share Of Common Stock; Terms Not Disclosed
Author: Benzinga Newsdesk | January 16, 2024 08:47am
The Company expects to grant the underwriters a 30-day option to purchase up to an additional 675,000 shares of common stock and/or additional warrants to purchase up to 675,000 shares of common stock
The Company expects to grant the underwriters a 30-day option to purchase up to an additional 675,000 shares of common stock and/or additional warrants to purchase up to 675,000 shares of common stock
Posted In: AXDX